Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person24
Lyell Immunopharma, Inc.
Company
Estrella Immunopharma, Inc.
Company
Immix Biopharma, Inc.
Company
Immunome Inc.
Company
GT Biopharma, Inc.
Company
IGC Pharma, Inc.
Company
Cue Biopharma, Inc.
Company
Immunovant, Inc.
Company
AEON Biopharma, Inc.
Company
AYTU BIOPHARMA, INC
Company
Lantern Pharma Inc.
Company
ABVC BIOPHARMA, INC.
Company
IMMUNIC, INC.
Company
Vitro Biopharma, Inc.
Company
Regen BioPharma Inc
Company
SUTRO BIOPHARMA, INC.
Company
Zenas BioPharma, Inc.
Company
aTYR PHARMA INC
Company
Silo Pharma, Inc.
Company
Propanc Biopharma, Inc.
Company
Benitec Biopharma Inc.
Company
Liminatus Pharma, Inc.
Company
Helus Pharma Inc.
Company
Traws Pharma, Inc.
Company
Primary record6
Lyell Immunopharma, Inc. filed 4
SEC form 4 filed by Lyell Immunopharma, Inc. (CIK 1806952) on 2026-11-05.
Lyell Immunopharma, Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 4, 2026, Lyell Immunopharma, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2026. A c
Lyell Immunopharma, Inc. filed 8-K
Item 3.02 Unregistered Sales of Equity Securities. On November 3, 2026, Lyell Immunopharma, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certa
Lyell Immunopharma, Inc. filed 8-K
Item 8.01. Other Events. On September 10, 2026, Lyell Immunopharma, Inc. (the “Company”) issued a press release (the “LYL273 Press Release”) regarding the completion of the technology transfer for LYL273 to the Company’s
Lyell Immunopharma, Inc. filed 4
SEC form 4 filed by Lyell Immunopharma, Inc. (CIK 1806952) on 2026-09-10.
Lyell Immunopharma, Inc. filed 4
SEC form 4 filed by Lyell Immunopharma, Inc. (CIK 1806952) on 2026-08-25.